Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart.
AUTOR(ES)
Wharton, J
RESUMO
Atrial natriuretic peptide immunoreactivity was found in ventricular and atrial tissues with specific antisera raised to the amino and carboxy terminal regions of the precursor molecule. In 13 developing human hearts (7-24 weeks' gestation) the immunoreactivity was concentrated in the atrial myocardium and ventricular conduction system but it was also detected in the early fetal ventricular myocardium. Immunoreactivity in five normal adults was largely confined to the atrial myocardium although it was also found in the ventricular conduction tissues of hearts removed from 10 patients who were undergoing cardiac transplantation. The ventricular conduction system is an extra-atrial site for the synthesis of atrial natriuretic peptide. In the failing heart this synthesis may be further supplemented by expression of the gene in the ventricular myocardium. It is possible that ventricular production of the peptide contributes to the raised circulating concentrations of atrial natriuretic peptide immunoreactivity found in severe congestive heart disease, particularly in patients with dilated cardiomyopathy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1216572Documentos Relacionados
- Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage.
- Natriuretic peptide receptor mRNAs in the rat and human heart.
- Specific heart granules and natriuretic peptide in the developing myocardium of fetal and neonatal rats and hamsters.
- Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
- Nornal and diseased vascular pattern of myocardium of human heart. I. Normal pattern in the left ventricular free wall.